Marine Natural Products as Breast Cancer Resistance Protein Inhibitors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Marine Natural Products as Breast Cancer Resistance Protein Inhibitors
Authors
Keywords
-
Journal
Marine Drugs
Volume 13, Issue 4, Pages 2010-2029
Publisher
MDPI AG
Online
2015-04-07
DOI
10.3390/md13042010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts
- (2015) Mylène Honorat et al. Oncotarget
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Marine Natural Products with P-Glycoprotein Inhibitor Properties
- (2014) Dioxelis Lopez et al. Marine Drugs
- Emerging Strategies and Integrated Systems Microbiology Technologies for Biodiscovery of Marine Bioactive Compounds
- (2014) Javier Rocha-Martin et al. Marine Drugs
- Lamellarin O, a Pyrrole Alkaloid from an Australian Marine Sponge, Ianthella sp., Reverses BCRP Mediated Drug Resistance in Cancer Cells
- (2014) Xiao-Cong Huang et al. Marine Drugs
- Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success
- (2014) Ana Martins et al. Marine Drugs
- Drug-Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
- (2014) Bruno O. Villoutreix et al. Molecular Informatics
- In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2014) Yi-Lung Ding et al. PLoS One
- Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein
- (2014) S. Erić et al. SAR AND QSAR IN ENVIRONMENTAL RESEARCH
- Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
- (2013) Golam Kibria et al. ARCHIVES OF PHARMACAL RESEARCH
- Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2
- (2013) Ya-peng Hu et al. BIOCHEMICAL PHARMACOLOGY
- Different strategies to overcome multidrug resistance in cancer
- (2013) Manju Saraswathy et al. BIOTECHNOLOGY ADVANCES
- ABCG2: recent discovery of potent and highly selective inhibitors
- (2013) Florine Lecerf-Schmidt et al. Future Medicinal Chemistry
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 2,5-Diketopiperazines from the Marine-Derived Fungus Aspergillus fumigatus YK-7
- (2012) Yu Wang et al. CHEMISTRY & BIODIVERSITY
- Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical Biology
- (2012) William H. Gerwick et al. CHEMISTRY & BIOLOGY
- 6-Halogenochromones Bearing Tryptamine: One-Step Access to Potent and Highly Selective Inhibitors of Breast Cancer Resistance Protein
- (2012) Glaucio Valdameri et al. ChemMedChem
- Asperjinone, a Nor-Neolignan, and Terrein, a Suppressor of ABCG2-Expressing Breast Cancer Cells, from Thermophilic Aspergillus terreus
- (2012) Wen-Ying Liao et al. JOURNAL OF NATURAL PRODUCTS
- Enhanced production of (+)-terrein in fed-batch cultivation of Aspergillus terreus strain PF26 with sodium citrate
- (2012) Ying Yin et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein
- (2011) Kapil Juvale et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Secalonic Acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathway
- (2011) Jian-ye Zhang et al. CELL CYCLE
- Substituted Chromones as Highly Potent Nontoxic Inhibitors, Specific for the Breast Cancer Resistance Protein
- (2011) Glaucio Valdameri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Three New Compounds from Aspergillus terreus PT06-2 Grown in a High Salt Medium
- (2011) Yi Wang et al. Marine Drugs
- A new compound, jolynamine, from marine brown algaJolyna laminarioides
- (2011) Abdul Majeed Khan et al. NATURAL PRODUCT RESEARCH
- Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungusGliocladiumsp. T31
- (2011) Ren Hong PHARMACEUTICAL BIOLOGY
- The “Specific” P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) Pavitra Kannan et al. ACS Chemical Neuroscience
- Mutational Analysis of Threonine 402 Adjacent to the GXXXG Dimerization Motif in Transmembrane Segment 1 of ABCG2
- (2010) Orsolya Polgar et al. BIOCHEMISTRY
- Synthesis and structure–activity relationship of botryllamides that block the ABCG2 multidrug transporter
- (2010) Kentaro Takada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of ABCG2-mediated drug efflux by naphthopyrones from marine crinoids
- (2010) Heidi R. Bokesch et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Enhancement of osteoblast biocompatibility on titanium surface with Terrein treatment
- (2010) Young-Hee Lee et al. CELL BIOCHEMISTRY AND FUNCTION
- Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2010) Zhanglin Ni et al. CURRENT DRUG METABOLISM
- Botryllamides: Natural Product Inhibitors of ABCG2
- (2009) Curtis J. Henrich et al. ACS Chemical Biology
- Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation energy approach
- (2009) Edwige Nicolle et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Systematic computational analysis of structure–activity relationships: concepts, challenges and recent advances
- (2009) Lisa Peltason et al. Future Medicinal Chemistry
- A New Terrein Glucoside, a Novel Inhibitor of Angiogenin Secretion in Tumor Angiogenesis
- (2009) Masayuki Arakawa et al. JOURNAL OF ANTIBIOTICS
- The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells
- (2009) Yonggang Ma et al. PHYTOTHERAPY RESEARCH
- Structure–activity relationships of new inhibitors of breast cancer resistance protein (ABCG2)
- (2008) Anne Pick et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Virtual screening of GPCRs: An in silico chemogenomics approach
- (2008) Laurent Jacob et al. BMC BIOINFORMATICS
- Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)
- (2008) Hong-May Sim et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues
- (2008) Yi Han et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Terrein Reduces Pulpal Inflammation in Human Dental Pulp Cells
- (2008) Jung-Chang Lee et al. JOURNAL OF ENDODONTICS
- Cytotoxic Alkaloids and Antibiotic Nordammarane Triterpenoids from the Marine-Derived FungusAspergillus sydowi
- (2008) Min Zhang et al. JOURNAL OF NATURAL PRODUCTS
- Homology modeling of breast cancer resistance protein (ABCG2)
- (2008) Eszter Hazai et al. JOURNAL OF STRUCTURAL BIOLOGY
- Seven new prenylated indole diketopiperazine alkaloids from holothurian-derived fungus Aspergillus fumigatus
- (2008) Fazuo Wang et al. TETRAHEDRON
- Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein
- (2007) Xiao-Ling Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search